There’s a lot of fear around applying artificial intelligence to the life sciences.
And while Diogo Rau, EVP and Chief Information and Digital Officer of Eli Lilly and Company, concedes that there are risks associated with using AI, the biggest risk is that we won’t use it.
On this episode, Diogo joins host Dr. Gautam Gulati to discuss the use of AI to facilitate clinical trials and drug discovery in a patient-first world. He explains how he is bringing Apple’s focus on the end user to life sciences, sharing his vision of what an Apple-like healthcare experience looks like and how to create a culture of innovation at Lilly.
Listen in: www.hlth.com/digital-content/hlth-matters/podcast/…